Frequency of edema in patients with pulmonary arterial hypertension receiving ambrisentan.
about
Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertensionThe role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)Clinical Adverse Effects of Endothelin Receptor Antagonists: Insights From the Meta-Analysis of 4894 Patients From 24 Randomized Double-Blind Placebo-Controlled Clinical Trials.Effectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials)Comparative safety and tolerability of endothelin receptor antagonists in pulmonary arterial hypertension.Endothelin research and the discovery of macitentan for the treatment of pulmonary arterial hypertension.Involvement of Cytokines in the Pathogenesis of Salt and Water Imbalance in Congestive Heart Failure.Ambrisentan: a review of its use in pulmonary arterial hypertension.Ambrisentan therapy in pulmonary hypertension: clinical use and tolerability in a referral centre.Safety, tolerability, pharmacokinetics, and pharmacodynamics of macitentan, an endothelin receptor antagonist, in an ascending multiple-dose study in healthy subjects.The safety of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension: Protocol for a systemic review and network meta-analysis.
P2860
Q26747812-B5811BB5-B592-4ACF-A5BD-018343486C90Q27013946-47516A4E-CCEF-4080-9C43-E5AC7F2C0E95Q36212186-A2AEAEA7-85E3-4D0C-A540-7B2C6CA62EADQ37531525-A9E1EF6C-C6D5-49EE-92AC-DF93115B251DQ38384575-9D7B2DE5-A4C8-48E2-9718-ED66EF85489CQ38559413-FB526FDC-BF35-469F-AD5B-07B45B37C16CQ38695069-B4448F44-268A-4149-8456-507062438FA6Q39251587-DDD929FF-2631-4F37-883B-9AB76DD5F794Q44394935-A03061E5-2623-46A3-A5DB-DDE9CCE844DBQ47895451-31138FF9-674B-4A80-B888-58D3C2B13D65Q54965707-A04A458C-CF85-46E2-9B76-4783A7FF21C5
P2860
Frequency of edema in patients with pulmonary arterial hypertension receiving ambrisentan.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Frequency of edema in patients ...... tension receiving ambrisentan.
@ast
Frequency of edema in patients ...... tension receiving ambrisentan.
@en
Frequency of edema in patients ...... tension receiving ambrisentan.
@nl
type
label
Frequency of edema in patients ...... tension receiving ambrisentan.
@ast
Frequency of edema in patients ...... tension receiving ambrisentan.
@en
Frequency of edema in patients ...... tension receiving ambrisentan.
@nl
prefLabel
Frequency of edema in patients ...... tension receiving ambrisentan.
@ast
Frequency of edema in patients ...... tension receiving ambrisentan.
@en
Frequency of edema in patients ...... tension receiving ambrisentan.
@nl
P2093
P2860
P1476
Frequency of edema in patients ...... tension receiving ambrisentan.
@en
P2093
Christiana Blair
Crystal Anglen
David M Pollock
Donald E Kohan
Hunter Gillies
Martine Allard
Noreen Henig
Shelley Shapiro
P2860
P304
P356
10.1016/J.AMJCARD.2012.06.040
P407
P577
2012-08-02T00:00:00Z